BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 32895756)

  • 21. Assessment of Ceftazidime-Avibactam 30/20-μg Disk, Etest versus Broth Microdilution Results When Tested against
    Han R; Yang X; Yang Y; Guo Y; Yin D; Ding L; Wu S; Zhu D; Hu F
    Microbiol Spectr; 2022 Feb; 10(1):e0109221. PubMed ID: 35019685
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of Rapid Immunochromatographic Tests for the Direct Detection of Extended Spectrum Beta-Lactamases and Carbapenemases in Enterobacterales Isolated from Positive Blood Cultures.
    Keshta AS; Elamin N; Hasan MR; Pérez-López A; Roscoe D; Tang P; Suleiman M
    Microbiol Spectr; 2021 Dec; 9(3):e0078521. PubMed ID: 34878297
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fast-track identification of CTX-M-extended-spectrum-β-lactamase- and carbapenemase-producing Enterobacterales in bloodstream infections: implications on the likelihood of deduction of antibiotic susceptibility in emergency and internal medicine departments.
    Boattini M; Bianco G; Iannaccone M; Ghibaudo D; Almeida A; Cavallo R; Costa C
    Eur J Clin Microbiol Infect Dis; 2021 Jul; 40(7):1495-1501. PubMed ID: 33598829
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical characteristics and prognosis of infections caused by OXA-48 carbapenemase-producing Enterobacteriaceae in patients treated with ceftazidime-avibactam.
    De la Calle C; Rodríguez O; Morata L; Marco F; Cardozo C; García-Vidal C; Río AD; Feher C; Pellicé M; Puerta-Alcalde P; Mensa J; Soriano A; Martínez JA
    Int J Antimicrob Agents; 2019 Apr; 53(4):520-524. PubMed ID: 30471403
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of MASTDISCS combi Carba plus for the identification of metallo-β-lactamases, KPC and OXA-48 carbapenemase genes in Enterobacteriaceae clinical isolates.
    Hu W; Li M; Lu W; Guo S; Li J
    Lett Appl Microbiol; 2020 Jan; 70(1):42-47. PubMed ID: 31642085
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Problem of Carbapenemase-Producing-Carbapenem-Resistant-Enterobacteriaceae Detection.
    Lutgring JD; Limbago BM
    J Clin Microbiol; 2016 Mar; 54(3):529-34. PubMed ID: 26739152
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A single-day point-prevalence study of faecal carriers in long-term care hospitals in Madrid (Spain) depicts a complex clonal and polyclonal dissemination of carbapenemase-producing Enterobacteriaceae.
    Ruiz-Garbajosa P; Hernández-García M; Beatobe L; Tato M; Méndez MI; Grandal M; Aranzábal L; Alonso S; Lópaz MÁ; Astray J; Cantón R
    J Antimicrob Chemother; 2016 Feb; 71(2):348-52. PubMed ID: 26518051
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bloodstream infections due to carbapenemase-producing Enterobacteriaceae in Italy: results from nationwide surveillance, 2014 to 2017.
    Iacchini S; Sabbatucci M; Gagliotti C; Rossolini GM; Moro ML; Iannazzo S; D'Ancona F; Pezzotti P; Pantosti A
    Euro Surveill; 2019 Jan; 24(5):. PubMed ID: 30722813
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of avibactam-supplemented combination disk tests for the detection of OXA-48 carbapenemase-producing Enterobacteriaceae.
    Huang TD; Berhin C; Bogaerts P; Glupczynski Y
    Diagn Microbiol Infect Dis; 2014 Jun; 79(2):252-4. PubMed ID: 24731837
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluating NG-Test CARBA 5 Multiplex Immunochromatographic and Cepheid Xpert CARBA-R Assays among Carbapenem-Resistant
    Huang YT; Kuo YW; Lee NY; Tien N; Liao CH; Teng LJ; Ko WC; Hsueh PR;
    Microbiol Spectr; 2022 Feb; 10(1):e0172821. PubMed ID: 35019772
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of the MBT STAR-Carba Assay for the Detection of Carbapenemase Production in
    Cordovana M; Abdalla M; Ambretti S
    Microb Drug Resist; 2020 Nov; 26(11):1298-1306. PubMed ID: 32412820
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Influence of Antimicrobial Stewardship and Molecular Rapid Diagnostic Tests on Antimicrobial Prescribing for Extended-Spectrum Beta-Lactamase- and Carbapenemase-Producing Escherichia coli and Klebsiella pneumoniae in Bloodstream Infection.
    Kunz Coyne AJ; Casapao AM; Isache C; Morales J; McCarter YS; Jankowski CA
    Microbiol Spectr; 2021 Oct; 9(2):e0046421. PubMed ID: 34704795
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Investigation of carbapenemase genes and molecular epidemiology of Enterobacteriaceae strains isolated between 2010-2014 in a university hospitals].
    Kutlu HH; Us E; Tekeli A
    Mikrobiyol Bul; 2018 Jan; 52(1):1-12. PubMed ID: 29642825
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Outbreak of Klebsiella pneumoniae ST11 Resistant To Ceftazidime-Avibactam Producing KPC-31 and the Novel Variant KPC-115 during COVID-19 Pandemic in Argentina.
    Nicola F; Cejas D; González-Espinosa F; Relloso S; Herrera F; Bonvehí P; Smayevsky J; Figueroa-Espinosa R; Gutkind G; Radice M
    Microbiol Spectr; 2022 Dec; 10(6):e0373322. PubMed ID: 36445147
    [TBL] [Abstract][Full Text] [Related]  

  • 35.
    Kazmierczak KM; Bradford PA; Stone GG; de Jonge BLM; Sahm DF
    Antimicrob Agents Chemother; 2018 Dec; 62(12):. PubMed ID: 30249690
    [No Abstract]   [Full Text] [Related]  

  • 36. Epidemiology and in vitro activity of ceftazidime-avibactam, meropenem-vaborbactam, imipenem-relebactam, eravacycline, plazomicin, and comparators against Greek carbapenemase-producing Klebsiella pneumoniae isolates.
    Maraki S; Mavromanolaki VE; Magkafouraki E; Moraitis P; Stafylaki D; Kasimati A; Scoulica E
    Infection; 2022 Apr; 50(2):467-474. PubMed ID: 34854060
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Local prevalence of extended-spectrum beta-lactamase (ESBL) producing
    Díaz-Agero Pérez C; López-Fresneña N; Rincon Carlavilla AL; Hernandez Garcia M; Ruiz-Garbajosa P; Aranaz-Andrés JM; Maechler F; Gastmeier P; Bonten MJM; Canton R
    BMJ Open; 2019 Mar; 9(3):e024879. PubMed ID: 30826764
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of the synergy of ceftazidime/avibactam in combination with colistin, doripenem, levofloxacin, tigecycline, and tobramycin against OXA-48 producing Enterobacterales.
    Mataraci Kara E; Yilmaz M; Istanbullu Tosun A; Özbek Çelik B
    J Chemother; 2020 Jul; 32(4):171-178. PubMed ID: 32375606
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Deciphering variable resistance to novel carbapenem-based β-lactamase inhibitor combinations in a multi-clonal outbreak caused by Klebsiella pneumoniae carbapenemase (KPC)-producing Klebsiella pneumoniae resistant to ceftazidime/avibactam.
    Di Pilato V; Principe L; Andriani L; Aiezza N; Coppi M; Ricci S; Giani T; Luzzaro F; Rossolini GM
    Clin Microbiol Infect; 2023 Apr; 29(4):537.e1-537.e8. PubMed ID: 36414199
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Carbapenemase-producing Enterobacteriaceae in a tertiary hospital in Madrid, Spain: high percentage of colistin resistance among VIM-1-producing Klebsiella pneumoniae ST11 isolates.
    Pena I; Picazo JJ; Rodríguez-Avial C; Rodríguez-Avial I
    Int J Antimicrob Agents; 2014 May; 43(5):460-4. PubMed ID: 24657043
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.